Delivery Order SPE2DB20D9157-SPE2DB25FG62C
Award Date 9/8/25
Potential Completion Date 9/29/25
Potential Value $16K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on August 8, 2025. The delivery order covers Stelara 90 mg/mL syringes, a biologic immunosuppressant medication commonly used to treat autoimmune conditions. The award carries no set-aside designation, and the ultimate completion date is scheduled for August 29, 2025. This...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency's Medical Supply Chain on August 1, 2025. The delivery order is for Stelara 90 mg/ml syringes, with an ultimate completion date of August 22, 2025. This award carries no set-aside designation, allowing the vendor to compete on its merits within the broader federal procurement...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $32,499.90 on August 13, 2025, by the Defense Logistics Agency (DLA) for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, which is scheduled for completion by September 4, 2025, represents a continuation of the company's substantial role as a critical supplier within the federal pharmaceutical supply chain. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) for the supply of Stelara 90 mg/mL syringes. The contract, awarded on July 23, 2025, carries an ultimate completion date of August 13, 2025, and represents a direct delivery order with no set-aside designation. This award falls under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency for Stelara 90 mg/mL syringes. The award is issued under a firm fixed-price contract type with an ultimate completion date of August 28, 2025. This delivery order represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA, valued at...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency for $16,249.95 to supply Stelara 90 mg/mL syringes. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 21, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,499.90 by the Defense Logistics Agency (DLA) on August 12, 2025. The delivery order, which is expected to be completed by September 3, 2025, covers the supply of Stelara 90 mg/ml syringes to support Department of Defense healthcare facilities. This award was issued without a set-aside designation, demonstrating the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,249.95 on August 19, 2025, for the supply of Stelara 90 mg/ml syringes. The delivery order, which carries a firm fixed price and is not subject to any set-aside designation, is funded by the Defense Logistics Agency's Medical Supply Chain division and must be completed by September 10, 2025. This award represents a single delivery order...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency for Stelara 90 mg/ml syringes valued at $16,249.95. The contract, issued on July 31, 2025, with an ultimate completion date of August 21, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on July 30, 2025, for Stelara 90 mg/ml syringes with a ceiling value of $64,999.80. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, valued at $499,999,999 and effective through November 2026. The award carries...